Something went wrong with the connection!

Creative Diagnostics Announces the Launch of the PMMA Micro- and Nanoparticles

 Breaking News
  • No posts were found

Creative Diagnostics Announces the Launch of the PMMA Micro- and Nanoparticles

December 23
01:36 2020
Creative Diagnostics provides PMMA micro- and nanoparticles with multiple sizes from 25 nm to 750 µm.

New York, USA – December 22, 2020 – With years of experience in the pharmaceutical and life science sector, Creative Diagnostics provides a wide selection of uniform poly(methyl methacrylate) (PMMA) micro- and nanoparticles with multiple sizes from 25 nm to 750 µm, which can be applied for bioimaging, drug delivery, theranostics, biomedical devices, immunoasssay, and sensor. These PMMA micro- and nanoparticles are highly spherical, optically clear, and can be dissolved with solvents.

PMMA particles are hydrophilic, amorphous, transparent and colorless thermoplastics with excellent UV resistance. The sizes of these particles are determined by the photon correlation spectroscopy, scanning electron microscope or laser diffraction. Creative Diagnostics’ new PMMA particles can be applied in a variety of fields, including drug delivery, bioimaging and biomedical devices.

Included in this release are DiagPoly™ Amine Poly(Methyl Methacrylate) PMMA Nanoparticles, 25 nm, which are designed with amino groups on the surface, and are supplied in water, stable in aqueous media and to some extend in DMSO, with polydispersity index < 0.2. These particles are suitable for the covalent binding of proteins, antibodies or other molecules by glutaraldehyde activation, maleimide or SPDP functionalization.

Another example is DiagPoly™ Plain Fluorescent Poly(Methyl Methacrylate) PMMA Nanoparticles, Red, 25 nm, which are encapsulated with red fluorophores (excitation: 552 nm, emission: 580 nm) with no additional coatings or special functional groups on the surface. These particles are supplied in water, with polydispersity index < 0.2, and are applicable for fluorescent imaging and multimodal imaging.

“Creative Diagnostics always try to provide customers with unique solutions and innovative products, and we are very excited to combine our strengths to release these PMMA micro- and nanoparticles. Nanoparticles can be widely used in biology and medicine and we believe at Creative Diagnostics you can find the most comprehensive list of nanoparticles products with different sizes and surface properties to meet your research and industrial development needs.” said Dr. Jessica Waldorf, chief scientific officer of R&D department, at Creative Diagnostics.

“Creative Diagnostics is glad to fulfill researchers’ various study needs and offer customers access to Creative Diagnostics’ quality and comprehensive nanoparticles products and solutions to improve the performance of their studies. We always ensure that the most reliable data is provided to our customers.” said Alex, one of a senior scientific officers at Creative Diagnostics.

For more detailed information on PMMA micro- and nanoparticles or to discuss your project, please contact Creative Diagnostics directly. You’ll find more about their newly released products and services.

About Creative Diagnostics

Creative Diagnostics is a global leading manufacturer and supplier of various nanoparticles, microparticles and their coatings for R&D and commercialization in a wide variety of application areas including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. It also offers various custom services including chemical surface-functionalized, fluorescent modification, antibody immobilization, nucleic acid and oligo conjugation to meet clients’ specifications.

Media Contact
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Email: Send Email
Phone: 1-631-346-0027
Country: United States
Website: https://www.cd-bioparticles.com

Related Articles